FASLODEX

Main information

  • Trade name:
  • FASLODEX 1 U. INJ
  • Dosage:
  • 250MG (IN 5ML. SOL. ETHANOL 96%)
  • Pharmaceutical form:
  • INJ
  • Composition:
  • 1 U.
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FASLODEX 1 U. INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

10-11-2017

Pending EC decision:  Fulvestrant Mylan, fulvestrant, Opinion date: 09-Nov-2017

Pending EC decision: Fulvestrant Mylan, fulvestrant, Opinion date: 09-Nov-2017

Europe - EMA - European Medicines Agency

13-10-2017

Pending EC decision:  Faslodex, fulvestrant, Opinion date: 12-Oct-2017

Pending EC decision: Faslodex, fulvestrant, Opinion date: 12-Oct-2017

Europe - EMA - European Medicines Agency

22-6-2017

Pending EC decision:  Faslodex, fulvestrant, Opinion date: 22-Jun-2017

Pending EC decision: Faslodex, fulvestrant, Opinion date: 22-Jun-2017

Europe - EMA - European Medicines Agency

23-3-2018

Faslodex (AstraZeneca AB)

Faslodex (AstraZeneca AB)

Faslodex (Active substance: Fulvestrant) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)1898 of Fri, 23 Mar 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/540/T/63

Europe -DG Health and Food Safety

10-1-2018

Fulvestrant Mylan (Mylan S.A.S.)

Fulvestrant Mylan (Mylan S.A.S.)

Fulvestrant Mylan (Active substance: fulvestrant) - New authorisation - Commission Decision (2018)133 of Wed, 10 Jan 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4649

Europe -DG Health and Food Safety

28-8-2017

FASLODEX (Fulvestrant) Injection [AstraZeneca Pharmaceuticals LP]

FASLODEX (Fulvestrant) Injection [AstraZeneca Pharmaceuticals LP]

Updated Date: Aug 28, 2017 EST

US - DailyMed

24-5-2017

Faslodex (AstraZeneca UK Limited)

Faslodex (AstraZeneca UK Limited)

Faslodex (Active substance: Fulvestrant) - Centralised - Yearly update - Commission Decision (2017)3642 of Wed, 24 May 2017

Europe -DG Health and Food Safety